{
    "organizations": [],
    "uuid": "49df182735c7e9db95a2f4c9fc4929d4e5308e86",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cellular-biomedicine-announces-pos/brief-cellular-biomedicine-announces-positive-clinical-data-of-knee-osteoarthritis-china-phase-i-trial-idUSASC09SMI",
    "ord_in_thread": 0,
    "title": "BRIEF-Cellular Biomedicine Announces Positive Clinical Data Of Knee Osteoarthritis China Phase I Trial",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 15 AM / Updated 13 minutes ago BRIEF-Cellular Biomedicine Announces Positive Clinical Data Of Knee Osteoarthritis China Phase I Trial Reuters Staff 2 Min Read   Cellular Biomedicine Group Inc : * CELLULAR BIOMEDICINE GROUP ANNOUNCES POSITIVE 48-WEEK CLINICAL DATA OF ALLOJOINâ„¢ HUMAN ADIPOSE-DERIVED MESENCHYMAL PROGENITOR CELL (HAMPC) KNEE OSTEOARTHRITIS (KOA) CHINA PHASE I TRIAL * CELLULAR BIOMEDICINE GROUP - STUDY SHOWED ALLOJOIN TO HAVE GOOD SAFETY TOLERANCE AND EARLY SIGNS OF EFFICACY IN PREVENTING CARTILAGE DETERIORATION * CELLULAR BIOMEDICINE - PRIMARY END POINT SHOWED A SIGNIFICANT IMPROVEMENT AT 12 WEEKS POST ALLOJOIN CELL THERAPY, CONTINUED IMPROVEMENT AT 48 WEEKS * CELLULAR BIOMEDICINE - SECONDARY END POINT SHOWED INCREASED TENDENCY VERSUS THAT AT BASELINE 0 WEEKS, VERSUS NORMAL CARTILAGE DETERIORATION AS RESULT OF AGING * CELLULAR BIOMEDICINE - DE-PRIORITIZING U.S. ALLOJOIN OPERATION & CALIFORNIA INSTITUTE OF REGENERATIVE MEDICINE PROJECT TERMINATED, EFFECTIVE MARCH 14 * CELLULAR BIOMEDICINE - COMMON SIDE EFFECTS WERE TEMPORARY LOCAL REACTIONS INCLUDING SORENESS, SWELLING AT INJECTION SITE IN STUDY * CELLULAR BIOMEDICINE GROUP INC - TO DATE, NO SERIOUS ADVERSE EVENTS RELATED TO ALLOJOIN THERAPY HAVE BEEN REPORTED * CELLULAR BIOMEDICINE- 2 PATIENTS WHO UNDERWENT ONE DOSE OF INJECTIONS DROPPED OUT OF STUDY AS THEIR KNEE JOINTS WERE MORE PAINFUL AFTER INJECTION Source text for Eikon:  ",
    "published": "2018-03-16T13:15:00.000+02:00",
    "crawled": "2018-03-16T13:39:25.049+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "biomedicine",
        "announces",
        "positive",
        "clinical",
        "data",
        "knee",
        "osteoarthritis",
        "china",
        "phase",
        "trial",
        "reuters",
        "staff",
        "min",
        "read",
        "cellular",
        "biomedicine",
        "group",
        "inc",
        "cellular",
        "biomedicine",
        "group",
        "announces",
        "positive",
        "clinical",
        "data",
        "human",
        "mesenchymal",
        "progenitor",
        "cell",
        "hampc",
        "knee",
        "osteoarthritis",
        "koa",
        "china",
        "phase",
        "trial",
        "cellular",
        "biomedicine",
        "group",
        "study",
        "showed",
        "allojoin",
        "good",
        "safety",
        "tolerance",
        "early",
        "sign",
        "efficacy",
        "preventing",
        "cartilage",
        "deterioration",
        "cellular",
        "biomedicine",
        "primary",
        "end",
        "point",
        "showed",
        "significant",
        "improvement",
        "week",
        "post",
        "allojoin",
        "cell",
        "therapy",
        "continued",
        "improvement",
        "week",
        "cellular",
        "biomedicine",
        "secondary",
        "end",
        "point",
        "showed",
        "increased",
        "tendency",
        "versus",
        "baseline",
        "week",
        "versus",
        "normal",
        "cartilage",
        "deterioration",
        "result",
        "aging",
        "cellular",
        "biomedicine",
        "allojoin",
        "operation",
        "california",
        "institute",
        "regenerative",
        "medicine",
        "project",
        "terminated",
        "effective",
        "march",
        "cellular",
        "biomedicine",
        "common",
        "side",
        "effect",
        "temporary",
        "local",
        "reaction",
        "including",
        "soreness",
        "swelling",
        "injection",
        "site",
        "study",
        "cellular",
        "biomedicine",
        "group",
        "inc",
        "date",
        "serious",
        "adverse",
        "event",
        "related",
        "allojoin",
        "therapy",
        "reported",
        "cellular",
        "patient",
        "underwent",
        "one",
        "dose",
        "injection",
        "dropped",
        "study",
        "knee",
        "joint",
        "painful",
        "injection",
        "source",
        "text",
        "eikon"
    ]
}